Skip to main content

Table 2 Objective responses and survival of the study population

From: The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

Variable

No. of Patients [cases (%)]

Median PFS

Median OS

(95% CI, months)

(95% CI, months)

Best response

 Complete response

0

 Partial response

21 (32.3)

7.80 (4.86–10.74)

18.17 (12.89–23.45)

 Stable disease

27 (41.5)

7.00 (4.43–9.57)

13.00 (9.68–16.32)

 Progressive disease

16 (24.6)

1.93 (1.59–2.28)

4.30 (3.58–5.02)

 Could not be evaluated

1 (1.5)

Objective response ratea

21 (32.3)

Disease control rateb

48 (73.8)

  1. OS overall survival, PFS progression free survival, CI confidence interval
  2. aThe rate of objective response was defined as the percentage of patients who had a complete response or a partial response
  3. bThe rate of disease control was defined as the percentage of patients who had a complete response, partial response, or stable disease